why is compounded semaglutide not working the same as FDA-approved. The FDA has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before FDA Warns on Certain Forms

In obesity therapy, the threat of an adverse pharmaceutical cocktail isnt uncommon, so this screening is essential for secure treatment

Semaglutide is a medication primarily used for the treatment of type 2 diabetes and obesity, functioning as a GLP-1 receptor agonist to help regulate blood sugar levels and promote weight loss

Improved patient care leads to more successful treatment outcomes and greater overall satisfaction

Actualmente no podemos enviar medicamentos a

Call us to schedule an initial case review.

Interestingly, treatment of mouse cardiomyocytes with GLP-1 936 amide (a GLP-1 degradation product in vivo) resulted in Akt activation, extracellular regulated kinase (ERK) phosphorylation, and reduced apoptosis induced by hypoxia or hydrogen peroxide stress, implying an unconventional action of GLP-1 (Ban et al., 2010)